Ragaglitazar (NNC-61-0029; NN-622; (-)-DRF-2725) is a novel and potent PPARalpha and PPARgamma dual agonist (PPARα and PPARγ dual stimulator) with lipid-lowering and insulin-sensitizing efficacy in animal models. Ragaglitazar improves glycemic control and lipid profile in type 2 diabetes.

纯度：≥98%

CAS：222834-30-2